Mortality from infectious diseases remains a leading cause of death worldwide, making the development of new vaccines an important priority of biomedical research. Immunologic memory is a cardinal feature of adaptive immunity and an important goal of vaccination strategies. Traditional vaccination strategies are very effective at generating neutralizing antibodies against bacteria and viruses. However, a vaccine capable of generating robust T lymphocyte memory is still beyond our research, due, in part, to an incomplete understanding of the basis of lymphocyte fate specification. In this study, we propose to study the role of proteasome degradation activity in controlling this process.
T lymphocytes are cells of the immune system that provide protection against infections. Vaccines generate different types of protective T lymphocytes. Our goal is to test new strategies that may improve vaccine efficacy.
